Navigation Links
BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb
Date:1/5/2012

IRVING, Texas, Jan. 5, 2012 /PRNewswire/ -- BT (NYSE: BT) today announced that it has signed a contract extension with Bristol-Myers Squibb to manage its global network services through 2017.

BT will help Bristol-Myers Squibb derive greater value from its network services through increased standardization and innovation. The contract extension covers outsourced networked services, including wide area and local area networks, as well as remote access, voice, and telephony infrastructure. It also includes sector leading compliance management tailored to the requirements of the pharmaceutical industry, and network security services. The contract extension is global in scope, covering all of Bristol-Myers Squibb locations.

"Working with Bristol-Myers Squibb isn't just about managing technology; it's about assuring highly reliable services that enable collaboration and communication," said Bas Burger, president Global Commerce in BT Global Services. "The needs of the pharmaceutical sector are complex, specific and submitted to stringent compliance requirements. When organizations remain focused on driving their business without worrying about technology, then we have done our job."

Rick Yborra, vice president, Network and Hosting Services at Bristol-Myers Squibb added: "The partnership we have built with BT is based on our confidence in their global operational capabilities and their ability to flex with our changing needs. BT provides us with the type of world-class network that is necessary for a global BioPharma company to operate effectively."

The first contract between BT and Bristol-Myers Squibb was signed in 2005.

About BT

BT is one of the world's leading providers of communications services and solutions, serving customers in more than 170 countries.  Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to our customers for use at home, at work and on the move; broadband and internet products and services and converged fixed/mobile products and services.  BT consists principally of four lines of business: BT Global Services, BT Retail, BT Wholesale and Openreach.

In the year ended 31 March 2011, BT Group's revenue was 20,076m pounds Sterling with profit before taxation of 1,717m pounds.

British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group.  BT Group plc is listed on stock exchanges in London and New York.

For more information, visit www.btplc.com.

All news releases can be accessed at our web site: http://www.btplc.com/news

 


'/>"/>
SOURCE BT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fero Industries Signs New Distribution Agreement to Expand Sucanon® Presence in the Middle East
2. Mindray Signs Agreement With Novation
3. Sanomedics Signs Letter of Intent to Acquire East Coast Based Durable Medical Equipment Business
4. Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen
5. Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner
6. Sanomedics Signs Letter of Intent to Acquire Large Sleep Disorder Service Based Operation
7. South Korea Signs Accord with Abu Dhabi Health Authority on Hospital Service Agreement
8. GeckoSystems Signs Mobile Robot Joint Venture With Chinese Wheelchair Manufacturer
9. IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
10. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
11. Bend Research Signs Technology Licensing Agreement with Merck
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):